This out-of-favor drug maker is taking the steps needed to ensure it not only survives but thrives over the long term.
October 2025 broke an eight-month-long losing streak for dividend-paying stocks in the U.S. stock market. Read more here.
The S&P/ASX 300 Index (ASX: XKO) stock pays fully franked dividends and is forecast to surge 19% in 12 months. Here’s why.
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback